Results 81 to 90 of about 29,187 (219)

Plasma insulin levels are increased by sertraline in rats under oral glucose overload

open access: yesBrazilian Journal of Medical and Biological Research, 2001
Recognition and control of depression symptoms are important to increase patient compliance with treatment and to improve the quality of life of diabetic patients.
Gomez R.   +3 more
doaj  

84 Using Opportunistic Sampling and Remnant Blood Samples to Develop Pediatric Pharmacokinetic Models to Inform Antidepressant Dosing

open access: yesJournal of Clinical and Translational Science
OBJECTIVES/GOALS: Developing pharmacokinetic (PK) models to guide selective serotonin reuptake inhibitor (SSRI) dosing in youth is costly, time-intensive, and requires large numbers of participants. We evaluated the use of remnant blood samples from SSRI-
Jeffrey R. Strawn   +7 more
doaj   +1 more source

Ecchymosis due to sertraline use: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Sertraline is a widely used antidepressant due to its low adverse effect profile. Hematological adverse effects related to sertraline are uncommon. This report includes a case which presented to an emergency department with a large ecchymotic lesion on ...
Orhan Cinar   +4 more
doaj  

Mean prolactin levels before PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).

open access: yes, 2013
Mean prolactin levels before PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).
Sollip Kim (491807)   +1 more
core   +1 more source

Combining dance movement therapy and pharmacotherapy in adolescents with major depressive disorder: A randomized controlled study

open access: yesPediatric Investigation, EarlyView.
The current study was among the first clinical trials that combined dance movement therapy (DMT) and pharmacotherapy to enhance self‐esteem and alleviate anxious and depressive symptoms in adolescents with major depressive disorder. Results indicated that DMT combined with pharmacotherapy improved depression symptoms more than pharmacotherapy alone ...
Yanru Liu   +7 more
wiley   +1 more source

Sertraline-induced rectal bleeding and anal pain (a rare case presentation)

open access: yesCaspian Journal of Internal Medicine, 2022
Background: Selective serotonin reuptake inhibitors (SSRIs) have proven more problematic in terms of some side effects than the original clinical trials suggested.
Pezhman Hadinezhad, Hamzeh Hosseini
doaj  

Mean prolactin levels after PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).

open access: yes, 2013
Mean prolactin levels after PEG among patients taking escitalopram, paroxetine, and sertraline (ESC; escitalopram, PRX; paroxetine, SERT; sertraline).
Sollip Kim (491807)   +1 more
core   +1 more source

Evidence for cardiotoxicity associated with sertraline in rats [PDF]

open access: yes, 2018
WOS: 000444248700007PubMed ID: 30310659Sertraline is an antidepressant that is frequently prescribed to treat depression, obsessive-compulsive disorder, panic disorder, and anxiety.
Ilgın, Sinem   +6 more
core   +1 more source

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

open access: yesPM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen   +7 more
wiley   +1 more source

A UHPLC METHOD FOR SERTRALINE DETERMINATION

open access: yes, 2017
Purpose: To develop and implement a UHPLC method for quantitative determination of sertraline in biological samples – mostly human blood and urine. Material&Methods: Blood and urine samples available from Laboratory of analytical toxicology and Clinic ...
Georgi Bonchev   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy